Storia in 7 fonti

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

The FDA has reversed course and allowed uniQure to seek accelerated approval for the Huntington's gene therapy AMT-130 after Prasad and Makary's departures.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo20 g fa

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

The FDA has reversed course and allowed uniQure to seek accelerated approval for the Huntington's gene therapy AMT-130 after Prasad and Makary's departures.

originale

Timeline cronologica

mercoledì 17 giugno 2026·zerohedge.com
The Biology Won
The FDA blinks, giving Huntington’s patients hope—and uniQure shareholders a windfall.
mercoledì 17 giugno 2026·biopharmadive.com
UniQure to file gene therapy for approval, reflecting major shifts at FDA
The decision marks another regulatory U-turn following the exits of Marty Makary and Vinay Prasad, suggesting to some analysts that current FDA leadership may be more flexible in…

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

Confronto fonti

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

Timeline cronologica

The Biology Won

UniQure to file gene therapy for approval, reflecting major shifts at FDA

UniQure to file gene therapy for approval, reflecting major shifts at FDA

FDA Signals uniQure Huntington Gene Therapy Data Could Back Accelerated Approval - uniQure (NASDAQ:QURE)

Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

The Biology Won

Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

FDA Signals uniQure Huntington Gene Therapy Data Could Back Accelerated Approval - uniQure (NASDAQ:QURE)

"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency